The mechanism by which PI3 kinase/mTOR inhibition increases sensitivity of oestrogen receptor (ER)-positive breast cancers to CDK4/6 inhibition is by blocking cell cycle re-entry driven by cyclin D1 and by inducing apoptosis, according to findings presented during a session at the IMPAKT Breast Cancer Conference held 7–9 May 2015 in Brussels, Belgium.
Click here to read the article in full.
Source: ESMO
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.